ONCOLYTICS BIOTECH INC. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement
ONCOLYTICS BIOTECH INC. (ONCY) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement of CAD 8.73 as of 2018-12-31, per its 20-F filed 2019-03-15.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement · last filed 2019-03-15
- 2018-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 8.73 CAD.
- 2017-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 13.20 CAD; Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement as first filed 1.39 CAD.
- 2016-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 17.42 CAD; Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement as first filed 1.83 CAD.
- 2015-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement 20.58 CAD; Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement as first filed 2.17 CAD.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement as first filed |
|---|---|---|
| 2018-12-31 | 8.73 CAD 20-F · filed 2019-03-15 | |
| 2017-12-31 | 13.20 CAD 20-F · filed 2019-03-15 | 1.39 CAD 20-F · filed 2018-03-19 |
| 2016-12-31 | 17.42 CAD 20-F · filed 2019-03-15 | 1.83 CAD 20-F · filed 2018-03-19 |
| 2015-12-31 | 20.58 CAD 20-F · filed 2019-03-15 | 2.17 CAD 20-F · filed 2018-03-19 |
| 2014-12-31 | 3.19 CAD 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |